Genth-Zotz, S., Zotz, R., Geil, S., Voigtlander, T., Meyer, J. and Darius, H. (1999) Recombinant Growth Hormone Therapy in Patients with Ischemic Cardiomyopathy. Effects on Hemodynamics, Left Ventricular Function and Cardiopulmonary Exercise Capacity. Circulation, 99, 18-21.
https://doi.org/10.1161/01.CIR.99.1.18

has been cited by the following article:

• TITLE: Growth Hormone Replacement Therapy in Patients without Adult Growth Hormone Deficiency: What Answers Do We Have So Far?

  AUTHORS: Karine Rucker, Larissa Bianca Paiva Cunha de Sá, Alberto Krayyem Arbex

  KEYWORDS: Growth Hormone, Insulin-Like Growth Factor 1, Sarcopenia, Growth Hormone Replacement, Adult Growth Hormone Deficiency

  JOURNAL NAME: Health, Vol.9 No.5, May 18, 2017

  ABSTRACT: Growth hormone (GH) and insulin-like growth factor 1 (IGF-1) have been suggested as “anti-aging” therapies, or for improving quality of life with aging. In this study, we focus on the actions of GH in the main organs and organ systems of the human body, like skeletal muscle, bones and brain, particularly in regard to data and research on the use of GH replacement therapy in adults without growth hormone deficiency, especially elderly patients. Several different studies have been carried out to show what the effects and side effects of GH replacement in healthy people and what would be the impact in quality of life and life span. In this review, we demonstrate what answers we have so far about the effects of GH replacement in many organs and systems in healthy people.